SymbioCellTech
PrivateLast Round
Seed
Jun 24, 2016
Total Funding Raised
$7.5M
Company Overview
SymbioCellTech is a biotechnology company that develops stem cell-enabled therapies for the treatment of type 1 diabetes and other autoimmune and degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SymbioCellTech Comparables
Compare SymbioCellTech with similar companies based on industry and business-model similarity.
SymbioCellTech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 24, 2016 | ||||
| Seed | Aug 15, 2014 | ||||
| Seed | Mar 20, 2013 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors grew 37% MoM, reaching 973.
- Jun 24, 2016
$1.9M raised in Seed round
SymbioCellTech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SymbioCellTech's valuation, stock price, and market status.
Is SymbioCellTech a public or private company?
SymbioCellTech is a private company.
What is the current stock price of SymbioCellTech?
SymbioCellTech is a private company with no public stock price. No recent secondary market data is available.
How much is SymbioCellTech worth (valuation)?
Valuation information for SymbioCellTech is not publicly available.
Can I buy SymbioCellTech stock?
SymbioCellTech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SymbioCellTech's last funding round?
SymbioCellTech's most recent funding round was Seed on June 24, 2016.
Who are the main investors in SymbioCellTech?
Investor information for SymbioCellTech is not publicly disclosed.
Will SymbioCellTech IPO soon?
No public IPO plans have been announced for SymbioCellTech.
How can I track SymbioCellTech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SymbioCellTech's secondary market activity and sign up for updates.